381results about How to "Avoid necrosis" patented technology

Systems for optimizing anchoring force are described herein. In securing tissue folds, over-compression of the tissue directly underlying the anchors is avoided by utilizing tissue anchors having expandable arms configured to minimize contact area between the anchor and tissue. When the anchor is in its expanded configuration, a load is applied to the anchor until it is optimally configured to accommodate a range of deflections while the anchor itself exerts a substantially constant force against the tissue. Various devices, e.g., stops, spring members, fuses, strain gauges, etc., can be used to indicate when the anchor has been deflected to a predetermined level within the optimal range. Moreover, other factors to affect the anchor characteristics include, e.g., varying the number of arms or struts of the anchor, positioning of the arms, configuration of the arms, the length of the collars, etc.

A medical procedure utilizes a high-intensity focused ultrasound instrument having an applicator surface, a liquid-containing bolus or expandable chamber acting as a heat sink, and a source of ultrasonic vibrations, the applicator surface being a surface of a flexible wall of the bolus, the source of ultrasonic vibrations being in operative contact with the bolus. The applicator surface is placed in contact with an organ surface of a patient, the source is energized to produce ultrasonic vibrations focused at a predetermined focal region inside the organ, and a temperature of liquid in the bolus is controlled while the applicator surface is in contact with the organ surface to control temperature elevation in tissues of the organ between the focal region and the organ surface to necrose the tissues to within a desired distance from the organ surface.

Apparatus & methods for optimizing anchoring force are described herein. In securing tissue folds, over-compression of the tissue directly underlying the anchors is avoided by utilizing tissue anchors having expandable arms configured to minimize contact area between the anchor and tissue. When the anchor is in its expanded configuration, a load is applied to the anchor until it is optimally configured to accommodate a range of deflections while the anchor itself exerts a substantially constant force against the tissue. Various devices, e.g., stops, spring members, fuses, strain gauges, etc., can be used to indicate when the anchor has been deflected to a predetermined level within the optimal range. Moreover, other factors to affect the anchor characteristics include, e.g., varying the number of arms or struts of the anchor, positioning of the arms, configuration of the arms, the length of the collars, etc.

Apparatus & methods for optimizing anchoring force are described herein. In securing tissue folds, over-compression of the tissue directly underlying the anchors is avoided by utilizing tissue anchors having expandable arms configured to minimize contact area between the anchor and tissue. When the anchor is in its expanded configuration, a load is applied to the anchor until it is optimally configured to accommodate a range of deflections while the anchor itself exerts a substantially constant force against the tissue. Various devices, e.g., stops, spring members, fuses, strain gauges, etc., can be used to indicate when the anchor has been deflected to a predetermined level within the optimal range. Moreover, other factors to affect the anchor characteristics include, e.g., varying the number of arms or struts of the anchor, positioning of the arms, configuration of the arms, the length of the collars, etc.

The present invention relates generally to the utilization of in situ polymers or copolymers to form a porous microcellular scaffold for the delivery, attachment, housing, protection, multiplication and growth of encapsulated cells. More particularly, the present invention relates to cells delivered using such a scaffold to augment, repair or replace in vivo diseased, damaged or otherwise compromised tissues or organs of a living body.

Apparatus and methods for optimizing anchoring force are described herein. In securing tissue folds, over-compression of the tissue directly underlying the anchors is avoided by utilizing tissue anchors having expandable arms configured to minimize contact area between the anchor and tissue. When the anchor is in its expanded configuration, a load is applied to the anchor until it is optimally configured to accommodate a range of deflections while the anchor itself exerts a substantially constant force against the tissue. Various devices, e.g., stops, spring members, fuses, strain gauges, etc., can be used to indicate when the anchor has been deflected to a predetermined level within the optimal range. Moreover, other factors to affect the anchor characteristics include, e.g., varying the number of arms or struts of the anchor, positioning of the arms, configuration of the arms, the length of the collars, etc.

Methods, apparatus, and kits detect and / or treat vulnerable plaque of a blood vessel. A temperature differential can be sensed along a lumen surface with temperature sensors on a balloon filled with warm gas. Treatment methods include controlled and safe cryogenic cooling of vulnerable plaque to inhibit release of retained fluid within the vulnerable plaque so as to inhibit acute coronary syndrome and to help maintain patency of a body lumen.

Apparatus & methods for optimizing anchoring force are described herein. In securing tissue folds, over-compression of the tissue directly underlying the anchors is avoided by utilizing tissue anchors having expandable arms configured to minimize contact area between the anchor and tissue. When the anchor is in its expanded configuration, a load is applied to the anchor until it is optimally configured to accommodate a range of deflections while the anchor itself exerts a substantially constant force against the tissue. Various devices, e.g., stops, spring members, fuses, strain gauges, etc., can be used to indicate when the anchor has been deflected to a predetermined level within the optimal range. Moreover, other factors to affect the anchor characteristics include, e.g., varying the number of arms or struts of the anchor, positioning of the arms, configuration of the arms, the length of the collars, etc.

Systems for optimizing anchoring force are described herein. In securing tissue folds, over-compression of the tissue directly underlying the anchors is avoided by utilizing tissue anchors having expandable arms configured to minimize contact area between the anchor and tissue. When the anchor is in its expanded configuration, a load is applied to the anchor until it is optimally configured to accommodate a range of deflections while the anchor itself exerts a substantially constant force against the tissue. Various devices, e.g., stops, spring members, fuses, strain gauges, etc., can be used to indicate when the anchor has been deflected to a predetermined level within the optimal range. Moreover, other factors to affect the anchor characteristics include, e.g., varying the number of arms or struts of the anchor, positioning of the arms, configuration of the arms, the length of the collars, etc.

The invention relates to an irradiation device and method for the treatment of totally or partially cell-mediated inflammations of the skin, the connective tissue and the viscera, viral and other infectious diseases such as HIV and prionic infections, fungal infections of the skin and the mucous membranes, bacterial diseases of the skin and the mucous membranes as well hand eczema and anal eczema which comprises at least one irradiation device to irradiate a surface treatment area where the wavelength of the emitted radiation to a treatment area is longer than 400 nm and comprises at least one spectral band between 400-500 nm while the radiation device contains means for the generation of optical pulses towards a treatment area with a power density of the optical pulse peaks larger than 0.5 W / cm2 and smaller than 100 kW / cm2. The energy of one pulse relates to 0.05-10 J / cm2.

The invention discloses a quick breeding method of OT type hybrid system lily pull-off toxic group planting in plant group planting quick breeding technical domain, which comprises the following steps: allocating medium; choosing stem tip of lily seed source bulb as explant; evoking; breeding; expand-culturing bulb; freezing; replanting; testing virus; getting the product. This invention possesses high breeding coefficient, low cost and strong practicability, which can be spread used.

The invention relates to a three-dimensional (3D) bio-printed brain tumor in vitro model and a construction method thereof. The brain tumor in vitro model is obtained from a brain tumor cell-containing hydrogel system by preparing hydrogel fibers and constructing with a 3D bio-printer, wherein the hydrogel fibers has a diameter of 0.16-0.75mm, and has a volume filling percentage in the brain tumor in vitro model of 40-90 percent; the brain tumor cell-containing hydrogel system is prepared from the following raw materials: hyaluronic acid, sodium alginate, gelatin, glutamine transaminase and brain tumor cells. According to the brain tumor in vitro model, the 3D structure can be well maintained in the later culturing process, the problems of insufficient nutrition supply for cells inside large-sized hydrogel and biological characteristic and function loss of brain tumor cells when an existing brain tumor model is subjected to in vitro two-dimensional (2d) culture can be effectively solved.

A bowel control probe and method of detecting and preventing bowel incontinence. The probe has a body with a distal end which is permeable to gas. Conductivity sensors on the probe will establish an electrical circuit in the presence of fecal matter to send an alert signal to a control unit. The sensors may be partially shielded by a removable sleeve to reduce false alarms resulting from moisture. The control unit may issue an audible or visual alarm and may transmit a signal to a remote nursing station. An air cuff about the probe body is cyclically inflated and deflated to block passage of fecal matter and to protect tissue and capillaries in the rectal area.

Devices, systems, and methods can treat incontinence by heating between about 100 and about 800 cubic millimeters of endopelvic fascia for sufficient time to effect substantial collagenous tissue shrinkage. A probe body may directly engage the endopelvic fascia, or may be separated from the endopelvic fascia, heating through (for example) the vaginal wall. In either case, tissue-penetrating electrodes may be inserted from the probe body so as to heat the endopelvic fascia.

The present invention relates to 2-hydroxy-alkylamino-benzoic acid derivatives and to a combination of cell necrosis inhibitor and lithium, process for the preparation of the derivatives or the combination, pharmaceutical formulation containing the derivatives or the combination, and use of the derivatives or the combination by either concomitant or sequential administration for improvement of treatment of neuronal death or neurological dysfunction. The derivatives and the combination of the present invention are useful for treating neurological diseases, such as amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), spinal muscular atrophy, Alzheimer's disease, Parkinson's disease, Huntington's disease, stroke, traumatic brain injury or spinal cord injury; and for treating ocular diseases such as glaucoma, diabetic retinopathy or macular degeneration.

The invention discloses a leg reciprocating massaging wheel chair for a nursing department. The leg reciprocating massaging wheel chair comprises a base plate. The wheel chair is characterized in that a back plate is fixedly connected to the right side of the base plate, driving wheels are rotatably connected to the lower portion of the back plate, a motor base is fixedly connected to the middle of the base plate, a motor is fixedly connected to the position over the motor base, and a first sheave wheel is fixedly connected to the output end of the motor; a seat plate is fixedly connected to the left side of the back plate, the lower end of the seat plate is fixedly connected with the base plate, a first through groove is formed in the left side of the seat plate, and a massaging device is fixedly connected below the seat plate; a longitudinal rotating shaft is rotatably connected to the middle of the base plate. Compared with the prior art, the wheel chair has the advantages that the structure is simple, the cruising ability of a patient sitting on the wheel chair is greatly increased through electric drive, and the patient can move to a farther place; in addition, the massage device can be controlled to massage the leg of the patient, leg rehabilitation of the patient is promoted, and leg tissue necrosis of the patient can be effectively avoided.

The invention provides a subapical osteotomy locating guide plate and a manufacture method therefor. The subapical osteotomy locating guide plate belongs to assisting medical instruments. The subapical osteotomy locating guide plate comprises a locating occlusion plate (1), connecting rods (2) and maxillary osteotomy line guide plates (3). The locating occlusion plate (1) is provided with an initial tooth print (11) and is connected with the maxillary osteotomy line guide plates (3) via the connecting rods (2). Each maxillary osteotomy line guide plate (3) is provided with two screw holes (6). The maxillary osteotomy line guide plates (3) are provided with non-circular insertion grooves b (31). One end of each connecting rod (2) matches the corresponding insertion groove b (31). The subapical osteotomy locating plate solves the problem that no intermaxillary bone locating guide device is available in subapical osteotomy. When the subapical osteotomy locating guide plate is applied to assist doctors with surgeries, the current most common complication of subapical osteotomy can be prevented.

The invention relates to fig natural face-nourishing and weight-reducing cold herbal tea and a preparation method thereof, belonging to face-nourishing and weight-reducing cold herbal tea and a preparation method thereof. The cold herbal tea is prepared from fig, tea, Chinese dates, yam, vine roots, poria extract, hawthorn, alginate polysaccharide, soybean isoflavone, lotus leaf flavone, gypenosides, curcumin and white granulated sugar through the steps of crushing, extraction, preparation and the like. The cold herbal tea has the functions of beautifying the features, nourishing the face, reducing fat, losing weight, augmenting the breasts and getting sexy; and the cold herbal tea has the peculiar fruit tea taste of fig and is sour and sweet.

The invention provides a taraxacum oral liquid for expelling toxin, dehumidifying and benefiting gallbladder. The taraxacum oral liquid comprises the following active pharmaceutical ingredients in parts by weight: 10-50 parts of taraxacum, 10-20 parts of herba artemisiae scopariae, 10-20 parts of rabdosia serra, 10-20 parts of selfheal, 10-20 parts of radix bupleuri, 10-20 parts of radix paeoniae alba, 10-20 parts of corn silk, 10-20 parts of lalang grass rhizome, 10-20 parts of giant knotweed, 10-20 parts of euphrasia pectinata, 10-20 parts of scutellaria barbata, 10-20 parts of sedum sarmentosum, 10-20 parts of leonurus, 10-20 parts of trichosanthes kirilowi, 10-20 parts of cape jasmine fruit, 10-20 parts of herba ecliptae, 10-20 parts of polygonatum sibiricum, 10-20 parts of portulaca oleracea, 10-20 parts of radix rehmanniae, 10-20 parts of indigowoad root and 10-20 parts of lysimachia christinae Hance. The taraxacum oral liquid and the preparation method have the advantages that the traditional Chinese medicine extraction technology is greatly improved, so that toxic components in such Chinese herbs can be reduced to minimum, the taraxacum oral liquid can be absorbed by the human body, and the utilization ratio can be greatly improved.

The invention discloses pneumatic automatic hemostasis equipment and a pneumatic automatic hemostasis method. The method includes the steps of starting a timer to compute hemostasis time of a tourniquet acting on a wound surface; controlling a miniature air pump to suck in air via air inlet holes to inflate the tourniquet and acquiring an air pressure value in the tourniquet by an air pressure sensor; when the air pressure value is smaller than a first preset value, continuing controlling the miniature air pump to suck in the air via the air inlet holes to inflate the tourniquet; when the air pressure value is larger than a second preset value, controlling the miniature air pump to deflate the tourniquet via air outlet holes; when the air pressure value is between the first preset value and the second preset value, judging whether the hemostasis time reaches preset time or not; when the hemostasis time reaches the preset time, controlling a loudspeaker to play voice information to inform medical personnel of checking hemostasis conditions of the wound surface. The pneumatic automatic hemostasis equipment and the pneumatic automatic hemostasis method have the advantages that the problems of poor hemostatic effects caused by too high or too low hemostasis pressure of the tourniquet acting on the wound surface and wound tissue necrosis caused by long-time continuous vascular compression can be avoided effectively.

The self-supporting or automatic skin soft tissue dilator consists of dilating bag under the skin, connecting pipe and inflator connected successively. It features the connecting pipe extending from under skin to body surface and with section outside the body connected to an adjustable pressure-limiting valve via a T-union. The inflator is one elastic bag with air inlet connected to a non-return sucking valve and air outlet connected to a non-return outlet valve. The connecting pipe includes two sections connected via a sealing union. The pressure-limiting valve is also connected to a pressure gauge with red warning label beyond 60-80 mmHg area. The present invention is used to dilated under skin and has less pressure fluctuation.

The invention provides a root of tooth implant matrix containing silicon, calcium, phosphorus and sodium micro-arc oxidation coating and a preparation method thereof, relating to the field of implant material of a dental department. The invention aims at solving the problems that the existing root of tooth implants and metal ions of accessories thereof are easy to dissolve out to cause muscle tissue necrosis and the coating prepared on the surface of the implant through micro-arc oxidation is incomplete. The preparation method comprises the steps of selecting pure titanium or titanium alloy to be processed into the implant matrix and an oxidation fixture, polishing, washing and drying; and preparing the micro-arc oxidation bio-coating with micro-nano porous appearance on the external surface of the implant matrix by utilizing a micro-arc oxidation technology, taking out, washing and drying so as to obtain the root of tooth implant containing silicon, calcium, phosphorus and sodium micro-arc oxidation coating. According to the tooth implant matrix, biological active elements such as silicon, calcium, phosphorus and sodium are introduced into the coating, so that the root of tooth implant has apatite inducibility, the time for combining the implant and the bone is shortened, the part of the surface of the implant, contacted with the muscle tissue, can be completely oxidized due to the design of the fixture, the efficiency is high, no pollution is generated, and the tooth implant matrix is convenient to produce in large scale.

Methods, apparatus, and kits detect and / or treat vulnerable plaque of a blood vessel. A temperature differential can be sensed along a lumen surface with temperature sensors on a balloon filled with warm gas. Treatment methods include controlled and safe cryogenic cooling of vulnerable plaque to inhibit release of retained fluid within the vulnerable plaque so as to inhibit acute coronary syndrome and to help maintain patency of a body lumen.

The invention discloses high-calcium sandwiched chocolate and relates to the technical field of food processing. The high-calcium sandwiched chocolate is mainly prepared from the following components in parts by weight: 20-30 parts of white granulated sugar, 1-3 parts of sweet potato protein, 36-42 parts of a cocoa butter substitute, 6-8 parts of shrimp meal, 2-4 parts of lotus seed powder, 3-5 parts of oat bran phenol powder, 18-22 parts of whole milk powder, 1-3 parts of eel bone meal, 1-3 parts of lyophilized royal jelly, 4-6 parts of walnut powder, 2-4 parts of olive oil, 8-12 parts of carob flour, 8-10 parts of whey powder, 5-7 parts of lactose, 1-3 parts of soya bean lecithin, and edible essence. The high-calcium sandwiched chocolate is simple in production process and low in production cost, is pure in flavor and rich in nutrients, and meets the requirement of mass consumers.

The present invention is to provide a composition comprising of natural products of 5˜20 weight parts of Astragali Radix, 5˜10 weight parts of Atractyodis Rhizoma, 5˜10 weight parts of Notopterygii Rhizoma, 5˜10 weight parts of Langanae Cortex, 5˜10 weight parts of Lycii Fructus, 2˜10 weight parts of Cnidium Rhizoma, 2˜10 weight parts of Glycyrrhizae Radix, 2˜10 weight parts of Horn of Cervi Parvum, 5˜10 weight parts of Polygoni Multiflori Radix, 2˜10 weight parts of Paeonia Radix of which substances are powdered or extracted with water, alcohol or mixture thereof and the present composition has excellent neuro-protecting activity.

Engineered human tissue constructs are provided that are suitable for use in making humanized animals for use in pharmaceutical development. Humanized animals having the constructs implanted in vivo are provided. Methods of making and using the tissue-engineered constructs and humanized animals are also provided.

The invention discloses an inductive uterine slow release system. The incidence of uterine adhesion after an induced abortion operation is high, the re-adhesion is serious after a uterine adhesion operation, and no good solution is available at present. The system comprises a uterus-shaped elastic balloon stent, a slow release drug film, a catheter and a one-way inflation valve, wherein the uterus-shaped elastic balloon stent is a hollow isosceles triangle structural body; waists of the isosceles triangle are 3.5cm; the bottom edge of the isosceles triangle is 3cm; one end of the catheter is connected and communicated with the vertex angle end of the uterus-shaped elastic balloon stent; the other end of the catheter is connected with the one-way inflation valve; a plurality of annular scales are arranged on the outer side face of one end, close to the uterus-shaped elastic balloon stent, of the catheter; and the one-way inflation valve comprises an inflation valve and a pressure sensor. The uterus-shaped elastic balloon stent is coated with the slow release drug film, and the slow release drug film is made of fibrin glue and contains a slow release drug. The system is simple in structure and easy to operate, does not injure a uterine cavity easily, and can effectively avoid the uterine adhesion.